维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="Ninalga C"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Human bladder carcinoma is dominated by T - regulatory ceils and Thl inhibitory cytokines显示文摘	Loskog A Ninalga C Paul - Wetterberg G	2007	JUrol2007，177，1：	1
	2	CpGoligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immuni- ty in murine baadder cancer显示文摘	Ninalga C Loskog A Klevenfeldt M	2005	Immunother2005，28，1：	1
	3	CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD41 ( + ) T-cell immunity显示文摘	Mangsbo SM Ninalga C Essand M	2008	J Immunother2008，31，1：	1
	4	CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer显示文摘	Ninalga C Loskog A Klevenfeldt M	2005	J Immunother2005，28，1：	1
	5	Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors显示文摘	Loskog A Ninalga C Totterman TH	2006	Cancer Immunol Immunother2006，55，5：	1
	6	Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines显示文摘	Loskog A Ninalga C Paul-Wetterberg G		0，，01：	1
	7	CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+ T-cell Immunity显示文摘	Mangsbo S M Ninalga C Essand M	2008	J Immunother (1997)2008，31，1：	1
	8	CpG therapy is superior to BCG in an orthotopic bladder cancer model and gonerarates CD4 + T-cell immunity显示文摘	Mangsbo SM Ninalga C Essand M		0，，01：	1
	9	CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+T-cell Immunity显示文摘	Ninalga C Essand M	2008	J Immunother2008，31，1：	1
	10	Human bladder car- cinoma is dominated by T - regulatory cells and Thl inhibitory cyto- kines显示文摘	Loskog A Ninalga C Paul - Wetterberg G	2007	J Urol2007，177，1：	1
	11	Dendritic cells engineered to Express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors显示文摘	Loskog A Ninalga C T(o)tterman TH		0，，：	1
	12	CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer显示文摘	Ninalga C Loskog A Klevenfeldt M	2005	J Immunother2005，28，1：	1
	13	Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy 显示文摘	Loskog A Ninalga C Hedlund T	2005	Lab Anim2005，39，4：	1
	14	Human blad der carcinoma is dominated by T-regulatory cells and Thl inhibitory cytokines显示文摘	Loskog A Ninalga C Paul Wetterberg G	2007	J Urol2007，177，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费